The largest China-themed partnering conference during JPM Week
GRAND HYATT SAN FRANCISCO – Ballroom Level
345 Stockton St, San Francisco, CA, U.S.
1-ON-1 PARTNERING
Meet the right people and achieve your goals through one-to-one meetings.
Our Online partnering platform is now open. Registered attendees will receive sign-in email from Meeting Mojo.
ABOUT CHINA FOCUS @San Francisco
China Focus @San Francisco is a partnering forum designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.
- Investors (VC, PE, investment bank, etc.)
- Life science innovators and entrepreneurs
- Biotech & big pharma
- Medtech (device and diagnostics) manufacturers and distributors
- Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
- Healthcare providers
- Cross-border investment: money from the East and the West
- Innovations going to China: regulation, market access, manufacturing and distribution
- Chinese innovations going west: partnership for capital and market access in the U.S.
- Learn about Chinese life science and healthcare industry
- Hear about the latest Chinese regulatory reforms and implications
- Meet with the decision makers in the industry
- Initiate business conversations that otherwise difficult to start
Agenda
PLENARY SESSION
7:00-8:00
8:00-8:20
Miao Guo Smith, MBA , VP, Operations , MyBioGate
8:20-9:20
Discovering HER2, Herceptin –
And Opportunities for Future Breakthroughs through
Global-American-Chinese Research Collaboration – 2019 Lasker Award winner; Herceptin inventor, H. Michael Shepard
Global life science and healthcare investment and finance 2019 – Katherine Andersen, Head of Life Science & Healthcare, Silicon Valley Bank
9:20-10:50
Moderator: Helen Chen – Greater China Managing Partner, L.E.K. Consulting
Internationalization of Chinese companies in Healthcare – Dajian Cai, GTJA Investment Group
Phoenix Reborn--Innovative R&D Strategy and Plan of Gloria Biosciences – Helena Meng, VP and CMO, Gloria Biosciences
Rising China Biotech: The CStone Story – Shirley Zhao, CStone Pharma
Opportunities and challenges in China healthcare market – Helen Chen, L.E.K. Consulting
Fireside chat
Dajian Cai – Chairman, GTJA Investment Group
Shirley Zhao – Great China General Manager & Head of Commercial, CStone Pharma
Austin Zhu – President of Gloria Pharmaceuticals, General Manager of Gloria Biosciences
10:50-11:40
Moderator: Kim Nearing – Venture Partner, BVCF Management, ltd.
Panelists:
James Huang – Founding Partner, Panacea Venture; Managing Partner, KPCB China
Amy Tang – Venture Partner, Qiming Venture Partners
Bo Liu – Executive VP & Managing Director- Healthcare Investments, CDIB Capital
John Zhu – Partner, 6 Dimensions Capital
Mark Tang – Managing Director, Good Health Capital
Wendy Pan – Partner, Goodwin LLP
11:50-12:30
12:30-13:30
13:30-14:15
Moderator: Tianji Zhu, VP, CD Capital
Panelists:
Yonghui Shi – Managing Director, Metronic China Fund
Adam Zha – Partner, Anlong Fund
Yu Fang – Partner, 3E Bioventures Capital
Drake Yu – Founding Partner, LYFE Capital
14:15-15:00
Moderator: Dennis Purcell – Founder and Senior Advisor, Aisling Capital
Guest speakers:
Wei Jiang – Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC;
President, Bayer Group Greater China
15:00-15:15
Chunmei Chen – Chanmei Chen – Executive Deputy Director of Nanjing Municipal Jiangbei New Area Administrative Committee
15:15-15:30
15:30-16:15
Moderator: Paul Zhang – Partner, Bluestar Bioadvisors LLC; President, BioKatalyst
Panelists:
Bing Yuan – Chief Business Officer, Cstone Pharmaceuticals
Zhimin Jimmy Zhang – Venture Partner, Lilly Asia Ventures
Derek Small - Founding General Manager, Assembly Biosciences Research & Development Co. Shanghai
Jonathan Wang – Senior VP Head, Business Development, Zai Lab
Lingyun Dong – General Manager, Yeedozencom Science & Technology
16:15-17:00
Moderator: Jun Bao – President and CEO, Impact Therapeutics
Panelists:
Geffrey Gao – Executive VP/Deputy GM, Harbin Pharmaceutical Group
Larry Cai – Executive Director of BD, Fosun pharma
Xiangbin Xu – President, Simcere Innovation Center
Brad Loncar – CEO, Loncar Investments
Lu Cao - US Head of Corporate Banking for Chinese Multinationals, J.P. Morgan
11:00-12:00
Moderator: Echo Hindle-Yang – CEO at M.S.Q. Ventures
Panelists:
Hainian Zeng – CEO, Silexon AI Technology
Alan Jiang – CSO, XtalPi
Andrew Radin – CEO, twoXAR
Guo-liang Yu – Global CEO, Apollomics Inc
Daniel Teper – Co-Founder, Chairman & CEO, CYTOVIA Therapeutics
13:30-14:00
Zhen Chen – Chief Scientist & Deputy General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
14:00-14:15
Lingyun Dong – General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
14:15-15:00
Moderator: Lingyun Dong – General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
Panelists:
Zhen Chen – Chief Scientist & Deputy General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
Xiumin Huo – Professor of YEEHONG Business School
Zhi Xiao – Managing Director, SDIC Fund
Zhenyu Li – Business Development Director of LUNAN PHARMACEUTICAL GROUP CORP.
15:00-15:30
15:30-16:00
Zhen Chen – Chief Scientist & Deputy General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
10:00-11:00
Moderator: Alain Vertès – Managing Director, NxR Biotechnologies GmbH
Panelists:
Zhenhua Wu – CEO, Exegenesis Bio
Lynnet Koh – CEO, Targazyme
Jason Slingby – CBO, Oxford Biomedica
Frank Zhang – CEO, GenScript
11:10-11:40
Paul E. Burrows - Vice President of Jiangsu Industrial Technology Research Institute
11:40-11:50
Calvin Chen - CEO of CrossLinkBio,Inc.
12:00-13:00
13:00-13:20
13:30-14:30
14:30-18:00
10:00-10:05
Ginger Ding, Director of Investment Analyst, MyBioGate
10:05-12:30
Torbjorn Furuseth, CFO, Targovax
Lu Wang, Vice President, Flow Pharma
Ben Bobo, Founder & CEO, Cerenetx
Ping Rawson, Chief Financial Officer, Dyadic International
Franz Gruz, CEO, Maintect GmbH
Zhijun Zhang, CSO, Zhimeng Biopharma
Anna Sumeray, CEO, Virometix
Wen Luo, Denovo Biopharma
Scott Christensen, CEO, OncoGenesis
George Simeon, CEO, Curevo Vaccine
Lucy Lu, CFO, Kintor Pharmaceutical Limited
13:30-14:30
Huiru (Jane) Wang, CEO, Huirui Biopharma
Michael Tardugno, CEO, Celsion
Liming Yang, CEO, Wyze Biotech
Mark Colbrie, CEO, Strateos
14:30-15:15
Zhenhua Wu, CEO, Exegenesis Bio
David Poon, Vice President of Business Development, Zymeworks
Shawn Zhang, VP, Ambrx
Anu Balendran, Vice President Business Development, Alligator Bioscience
Darrin Crisitello, Chief Commercial Officer, Mission Bio
James Lee, Sr. Business Development Manager, Atomwise
15:15-17:30
Haijin Meng, Vice President, Chief Medical Officer, Gloria Biosciences
Sean Hu, CEO, Avotres
Peter Fedichev, CEO, Gero
Ying Chen, Senior Vice President of Marketing, Bayer Pharmaceuticals
Jiang Li, CEO, VivaLNK
Henry Oconnell, CEO, Canary Speech
Patrick Lopath, Co-founder and COO, TECLens, LLC
Chris Lai, CEO, METiS Pharmaceuticals
Mahmoud Rafea, Chief Scientist, Erythra
Dajian Cai
Chairman
GTJA Investment Group
James Huang
Managing Partner, KPCB China
Founding Partner, Panacea Venture
Head of U.S. Life Science & Healthcare Relationship Banking
Silicon Valley Bank
Venture Partner
Qiming Venture Partners
Managing Director
Cedrus Group
Chief Business Officer
CStone Pharmaceuticals
Derek Small
Director & Senior Advisor, former CEO
Assembly Bio
Partner
Bluestar BioAdvisors, LLC
CEO
Loncar Investments
Greater China Managing Partner
L.E.K Consulting
Bo Liu
Managing Director
CDIB Capital
Jimmy Zhang
Venture Partner
Lilly Asian Ventures
John Zhu
Partner
6 Dimensions Capital
Dennis Purcell
Founder and Senior Advisor
Aisling Capital
Dekel Gelbman
CEO
FDNA
Hai-Nian Zeng
CEO
Silexon AI Technology
Zhenhua Wu
President and CEO
Exegenesis Bio
Shawn Xu
Executive Director
Simcere Innovation, Inc.
Jun Bao
President and CEO
Impact Therapeutics
CEO and CSO
CARsgen Therapeutics
Alan Jiang
CSO
XtalPi
Alain Vertès
Managing Director
NxR Biotechnologies GmbH
Mark Tang
Founding Partner
Good Health Capital
Executive VP/Deputy GM
Harbin Pharmaceutical Group
Yong-Hui Shi
Head and Sr. Managing Director
Medtronic China Ventures
CEO
twoXAR
Attendees
Chinese Companies and Investors
%
Executive Level Attendees
One-to-one meetings
CHINA FOCUS @ JPM WEEK 2019
Panel 1: Money from the East: Opportunities and Challenges in Cross-border Collaboration
CHINA FOCUS @ JPM WEEK 2019
Panel 2: Partnering Opportunities with Chinese Pharma Companies
CHINA FOCUS @ JPM WEEK 2019
Panel 3: Selling to the West: Fund raising, Out-licensing and IPO Opportunities for China′ s Biotech Innovations
CHINA FOCUS @ JPM WEEK 2019
Panel 4: Current Healthcare Venture Capital Trends & Opportunities
Call for Sessions is now open for the China [email protected] Francisco! Create your session with us, you are more than just a listener.
Youwen (Allen) Dai
Registration, Sponsorship and Collaboration (U.S. and Europe)
Han Yan
GRAND HYATT SAN FRANCISCO
345 Stockton Street
San Francisco, CA 94108, USA
Phone: +1 415 398 1234
Fax: +1 415 391 1780